Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Willem Jan R. Fokkink"'
Autor:
Willem Jan R. Fokkink, Sander J. van Tilburg, Brenda C. M. de Winter, Sebastiaan D. T. Sassen, Pieter A. van Doorn, Birgit C. P. Koch, Bart C. Jacobs
Publikováno v:
Clinical Pharmacokinetics, 61(9), 1285-1296. Adis
Background and Objective: Intravenous immunoglobulin (IVIg) at a standard dosage is the treatment of choice for Guillain–Barré syndrome. The pharmacokinetics, however, is highly variable between patients, and a rapid clearance of IVIg is associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be3a5750ded07869774ceeba084c5405
https://doi.org/10.1007/s40262-022-01136-z
https://doi.org/10.1007/s40262-022-01136-z
Autor:
Sander J. van Tilburg, Pleuni Ooijevaar-de Heer, Willem-Jan R. Fokkink, Bart C. Jacobs, Ruth Huizinga, Gestur Vidarsson, Theo Rispens
Publikováno v:
European Journal of Immunology, 52(4), 609-617
European journal of immunology. Wiley-VCH Verlag
European journal of immunology. Wiley-VCH Verlag
Clinical efficacy of intravenous immunoglobulin treatment (IVIg) is related to its pharmacokinetic (PK) profile. Its usual evaluation, by measuring serum total IgG levels, is imprecise, because IVIg cannot be distinguished from endogenous IgG. We dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0118c863111d1e673e7ea8a063b1f9c0
https://pure.eur.nl/en/publications/2983635a-fd6a-4435-8107-d965de7e7957
https://pure.eur.nl/en/publications/2983635a-fd6a-4435-8107-d965de7e7957
Autor:
Willem Jan R Fokkink, David Falck, Tom C M Santbergen, Ruth Huizinga, Manfred Wuhrer, Bart C Jacobs
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139828 (2015)
Intravenous immunoglobulin (IVIg) products from different pharmaceutical companies vary in composition, in part because of the selected blood donors and production process. N-glycosylation of the Fc-portion of IgG varies between blood donors and may
Externí odkaz:
https://doaj.org/article/ae505205b0db44d2b41beec27cd3fcc4
Autor:
Krista Kuitwaard, Pieter A. van Doorn, Sietse Q. Nagelkerke, Sten P. Willemsen, Willem-Jan R. Fokkink, Merel C. Broers, Frank Baas, Bart C. Jacobs, Thiziri Bengrine, Wouter van Rijs, Carina Bunschoten, Taco W. Kuijpers, Ruth Huizinga
Publikováno v:
European Journal of Neurology, 28(5), 1677-1683. WILEY
European Journal of Neurology
European Journal of Neurology, 28(5), 1677-1683. Wiley-Blackwell Publishing Ltd
European journal of neurology, 28(5), 1677-1683. Wiley-Blackwell
European Journal of Neurology
European Journal of Neurology, 28(5), 1677-1683. Wiley-Blackwell Publishing Ltd
European journal of neurology, 28(5), 1677-1683. Wiley-Blackwell
Background and purpose Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a clinical and electrophysiological heterogeneous immune‐mediated polyneuropathy. Intravenous immunoglobulin (IVIg), corticosteroids, and plasma exchange are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::543a25b4660b6e634d80df196c9156d0
http://hdl.handle.net/1887/3196006
http://hdl.handle.net/1887/3196006
Autor:
Daan Nieboer, Ingemar S. J. Merkies, Hester F. Lingsma, Filip Eftimov, P.A. van Doorn, Bart C. Jacobs, Krista Kuitwaard, Esther Brusse, Nicolette C. Notermans, A. F. J. E. Vrancken, A. J. van der Kooi, Willem-Jan R. Fokkink
Publikováno v:
European Journal of Neurology, 28(1), 286-296. Wiley-Blackwell Publishing Ltd
European journal of neurology, 28(1), 286-296. Wiley-Blackwell
European Journal of Neurology
European Journal of Neurology, 28(1), 286-296. Wiley
European journal of neurology, 28(1), 286-296. Wiley-Blackwell
European Journal of Neurology
European Journal of Neurology, 28(1), 286-296. Wiley
More frequent lower dosing does not further improve the efficacy of intravenous immunoglobulin (IVIg) in stable IVIg‐dependent chronic inflammatory demyelinating polyradiculoneuropathy. More frequent lower dosing does lead to more stable serum immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::392529bd96d4ec5c60048d3550a88e8e
https://pure.eur.nl/en/publications/3c2df758-444b-4fd5-b6af-5639f67cec25
https://pure.eur.nl/en/publications/3c2df758-444b-4fd5-b6af-5639f67cec25
Autor:
Noor E. Taams, Anne P. Tio-Gillen, Nicolette C. Notermans, Marco W.J. Schreurs, Willem-Jan R. Fokkink, Bart C. Jacobs, Ruth Huizinga
Publikováno v:
Journal of the Peripheral Nervous System, 23(4), 227-234. Wiley-Blackwell Publishing Ltd
Antibodies to the ganglioside GD1b have been reported in various forms of immune-mediated neuropathy, but their clinical relevance for diagnosis and prognosis is unknown. We investigated the prevalence of anti-GD1b antibodies in acute and chronic imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5dfba8a8fe97b0dc8598f1d95a9bcdf
https://doi.org/10.1111/jns.12285
https://doi.org/10.1111/jns.12285
Autor:
Ingemar S. J. Merkies, Esther Brusse, Anneke J. van der Kooi, Willem Jan R. Fokkink, Alexander F.J.E. Vrancken, Krista Kuitwaard, Filip Eftimov, Pieter A. van Doorn, Nicolette C. Notermans, Bart C. Jacobs
Publikováno v:
Journal of the Peripheral Nervous System. 23:5-10
High peak levels of serum IgG may not be needed for maintenance treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with intravenous immunoglobulin (IVIg). More frequent dosing of IVIg leads to more stable IgG levels and hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a11f2d5171efb3f75ef593a1f523e6
https://doi.org/10.1111/jns.12244
https://doi.org/10.1111/jns.12244
Autor:
Pieter A. van Doorn, Krista Kuitwaard, Bart C. Jacobs, Christa Walgaard, Anne P. Tio-Gillen, Willem-Jan R. Fokkink
Publikováno v:
JAMA Neurology, 74(2), 189-196. American Medical Association
Importance There is an urgent need for biomarkers to monitor treatment efficacy and anticipate outcome in patients with Guillain-Barre syndrome (GBS). Objective To assess whether there is an association between serum albumin levels, a widely used and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a0de8fe0e346fa73597d174ee956b5
https://pure.eur.nl/en/publications/10d25cce-67a5-4d33-9594-38071f0431fd
https://pure.eur.nl/en/publications/10d25cce-67a5-4d33-9594-38071f0431fd
Autor:
Anne P. Tio-Gillen, Pieter A. van Doorn, Willem-Jan R. Fokkink, Bart C. Jacobs, Annechien E. G. Haarman, Wouter van Rijs, Ruth Huizinga
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, 3(7), 547-551. John Wiley & Sons Inc.
Annals of Clinical and Translational Neurology, 3(7), 547-551. John Wiley & Sons Inc.
Treatment of Guillain‐Barré syndrome with a standard course of high‐dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc‐receptor p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6487af7ddbea4393ec5e71c41f6f0b16
http://europepmc.org/articles/PMC4931719
http://europepmc.org/articles/PMC4931719
Autor:
Liesbeth E. Bakker-Jonges, Bart C. Jacobs, Karin Geleijns, Pieter A. van Doorn, Janneke N. Samsom, Willem Jan R. Fokkink, Bianca van den Berg, Anne P. Tio-Gillen, Jon D. Laman, Wouter van Rijs, Ruth Huizinga
Publikováno v:
Annals of Neurology. 78:343-354
Objective: Guillain-Barre syndrome (GBS) is a postinfectious neuropathy most frequently caused by Campylobacter jejuni. Lipo-oligosaccharides (LOS), expressed by C. jejuni induce antibodies that cross-react with self-glycolipids in peripheral nerves,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47052be931e25292f644c9f4ba8b2350
https://doi.org/10.1002/ana.24442
https://doi.org/10.1002/ana.24442